Proteomic effects of short-term liraglutide vs. placebo in a blinded crossover RCT: Implications for efficacy, safety, and comparison with semaglutide

Metabolism 2026

View at publisher
Authors: Konstantinos Stefanakis, Valeria Gutierrez de Piñeres, Preethi Veeragandham, Christos S. Mantzoros
DOI: 10.1016/j.metabol.2026.156493
Cited by: 3
References: 31

Fields of Study & Subjects

Diabetes Treatment and Management Muscle Physiology and Disorders Bariatric Surgery and Outcomes

Publication details

Journal / source
Metabolism
Publisher
Elsevier BV
Volume
177
Pages
156493–156493
Publication date
7 January 2026
Language
EN